File Download
  Patent History
  • Application
    EP 20100834154 2010-12-06
  • Publication
    EP 2507263 2012-10-10
Supplementary

Patent: ANTI-IGF-IR ANTIBODIES AND USES THEREOF

TitleANTI-IGF-IR ANTIBODIES AND USES THEREOF
Priority Date2009-12-04 US 12/266681P
2010-12-06 PCT/CN2010001963
Inventors
Issue Date2012
Citation
EP Published Patent application EP 2507263. European Patent Office (EPO), Escapenet, 2012 How to Cite?
AbstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.
Persistent Identifierhttp://hdl.handle.net/10722/194061
References

 

DC FieldValueLanguage
dc.date.accessioned2014-01-29T05:23:46Z-
dc.date.available2014-01-29T05:23:46Z-
dc.date.issued2012-
dc.identifier.citationEP Published Patent application EP 2507263. European Patent Office (EPO), Escapenet, 2012en_US
dc.identifier.urihttp://hdl.handle.net/10722/194061-
dc.description.abstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documentsen_US
dc.titleANTI-IGF-IR ANTIBODIES AND USES THEREOFen_US
dc.typePatenten_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorZHANG, MEIYUNen_US
patents.identifier.applicationEP 20100834154en_US
patents.description.assigneeUNIV HONG KONG [CN]en_US
patents.description.countryEuropean Patent Officeen_US
patents.date.publication2012-10-10en_US
dc.relation.referencesXP 055058186en_US
dc.relation.referencesCN 101014625 (A) 2007-08-08en_US
dc.relation.referencesCN 101014625 (B) 2013-07-03en_US
dc.relation.referencesWO 2007012614 (A2) 2007-02-01en_US
dc.relation.referencesWO 2007012614 (A3) 2007-03-29en_US
dc.relation.referencesXP 008160352en_US
dc.relation.referencesXP 008160320en_US
patents.date.application2010-12-06en_US
patents.date.priority2009-12-04 US 12/266681Pen_US
patents.date.priority2010-12-06 PCT/CN2010001963en_US
patents.description.ccepen_US
patents.identifier.publicationEP 2507263en_US
patents.relation.familyCN 102753581 (A) 2012-10-24en_US
patents.relation.familyUS 2011135663 (A1) 2011-06-09en_US
patents.relation.familyUS 8444982 (B2) 2013-05-21en_US
patents.relation.familyWO 2011066721 (A1) 2011-06-09en_US
patents.description.kindA1en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats